Related references
Note: Only part of the references are listed.The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival
Xueping Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
Marawan Ahmed et al.
DRUG DISCOVERY TODAY (2015)
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
Davor Slijepcevic et al.
HEPATOLOGY (2015)
IL-35: A potential therapeutic target for controlling hepatitis B virus infection
Xiao Gang Xiang et al.
JOURNAL OF DIGESTIVE DISEASES (2015)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Tenofovir Rescue Regimen Following Prior Suboptimal Response to Entecavir and Adefovir Combination Therapy in Chronic Hepatitis B Patients Exposed to Multiple Treatment Failures
Qian Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Human PD-1 binds differently to its human ligands: A comprehensive modeling study
Clement Viricel et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
Limited Hepatitis B Immunoglobulin With Potent Nucleos(t)ide Analogue Is a Cost-Effective Prophylaxis Against Hepatitis B Virus After Liver Transplantation
G. A. Singer et al.
TRANSPLANTATION PROCEEDINGS (2015)
Correlation between TGF-β1 gene 29 T>C single nucleotide polymorphism and clinicopathological characteristics of osteosarcoma
Yang Wu et al.
TUMOR BIOLOGY (2015)
Molecular biology of hepatitis B virus infection
Christoph Seeger et al.
VIROLOGY (2015)
Interleukin 6 inhibits HBV entry through NTCP down regulation
Fidaa Bouezzedine et al.
VIROLOGY (2015)
Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
Wen Yin et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
Eric Lawitz et al.
ANTIVIRAL THERAPY (2015)
Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression
Senko Tsukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection
Ejuan Zhang et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
A review of non-nucleoside anti-hepatitis B virus agents
Fan Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide
Huan Yan et al.
JOURNAL OF VIROLOGY (2014)
The immune checkpoint inhibitors: where are we now?
Rachel Webster
NATURE REVIEWS DRUG DISCOVERY (2014)
RNA-Seq Based Transcriptome Analysis of Hepatitis E Virus (HEV) and Hepatitis B Virus (HBV) Replicon Transfected Huh-7 Cells
Neetu Jagya et al.
PLOS ONE (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
Anuj Gaggar et al.
VACCINE (2014)
Prospects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus
Augustine Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma
Zhi-Mei Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonist
Uri Lopatin et al.
ANTIVIRAL THERAPY (2013)
Synthesis and biological evaluation of helioxanthin analogues
Damodar Janmanchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Tackling hepatitis B virus-associated hepatocellular carcinoma-the future is now
Mausumi Bharadwaj et al.
CANCER AND METASTASIS REVIEWS (2013)
T Cells Expressing a Chimeric Antigen Receptor That Binds Hepatitis B Virus Envelope Proteins Control Virus Replication in Mice
Karin Krebs et al.
GASTROENTEROLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Phosphorylation of human La protein at Ser366 by casein kinase II contributes to hepatitis B virus replication and expression in vitro
J. Tang et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A systematic analysis of the predicted human La protein targets identified a hepatitis B virus infection signature
J. Tang et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A
Michael A. Carpenter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
Xin Gao et al.
PLOS ONE (2012)
A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation
Jing Tang et al.
PLOS ONE (2012)
Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
Khaled H. Barakat et al.
PLOS ONE (2012)
Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice
Wenzheng Jiang
VACCINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance
Yu-Ping Wang et al.
ANTIVIRAL RESEARCH (2011)
Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro
Ran Pang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
HBV life cycle and novel drug targets
Daniel Grimm et al.
HEPATOLOGY INTERNATIONAL (2011)
Effects of Interferon-α/β on HBV Replication Determined by Viral Load
Yongjun Tian et al.
PLOS PATHOGENS (2011)
Heat Stress Cognate 70 Host Protein as a Potential Drug Target against Drug Resistance in Hepatitis B Virus
Yu-Ping Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
Jung Min Lee et al.
ANTIVIRAL THERAPY (2010)
Molecular genesis of drug-resistant and vaccine-escape HBV mutants
Stephen A. Locarnini et al.
ANTIVIRAL THERAPY (2010)
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents
Damodar Janmanchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Review of Hepatitis B Therapeutics
Debika Bhattacharya et al.
CLINICAL INFECTIOUS DISEASES (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Hepatoprotective Effects of Sedum sarmentosum on D-Galactosamine/Lipopolysaccharide-Induced Murine Fulminant Hepatic Failure
Li-Hua Lian et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro
Wen-Sheng Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
-509C>T polymorphism in the TGF-β1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection
Peng Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China
Guang Bi Yao et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2009)
The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters
Ya Ping Tseng et al.
ANTIVIRAL RESEARCH (2008)
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Hiromi Yatsuji et al.
JOURNAL OF HEPATOLOGY (2008)
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
Jinlin Hou et al.
HEPATOLOGY (2008)
Bioactive constituents from Chinese natural medicines.: XXIII.: Absolute structures of new megastigmane glycosides, sedumosides A4, A5, A6, H, and I, and hepatoprotective megastigmanes from Sedum sarmentosum
Kiyofumi Ninomiya et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues
Matthieu Blanchet et al.
JOURNAL OF VIROLOGY (2007)
Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue
Chunxiao Ying et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
APOBEC3 proteins inhibit human LINE-1 retrotransposition
Heide Muckenfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
New targets and inhibitors of HBV replication to combat drug resistance
Yung-Chi Cheng et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus
PK Chua et al.
JOURNAL OF VIROLOGY (2005)
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
M Isogawa et al.
JOURNAL OF VIROLOGY (2005)
Clinical pharmacokinetics of alamifovir and its metabolites
C Chan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
DKW Soon et al.
JOURNAL OF HEPATOLOGY (2004)
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
CL Lai et al.
CLINICAL INFECTIOUS DISEASES (2003)
Antiviral activities of MCC-478, a novel and specific inhibitor of hepatitis B virus
N Kamiya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus
SK Ono-Nita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site
T Heise et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
